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Middle East respiratory syndrome coronavirus (MERS-CoV) causes a
zoonotic respiratory disease of global public health concern, and
dromedary camels are the only proven source of zoonotic infection.
AlthoughMERS-CoV infection is ubiquitous in dromedaries across Africa
aswell as in the Arabian Peninsula, zoonotic disease appears confined to
the Arabian Peninsula. MERS-CoVs from Africa have hitherto been
poorly studied. We genetically and phenotypically characterized MERS-
CoV from dromedaries sampled in Morocco, Burkina Faso, Nigeria, and
Ethiopia. Viruses from Africa (clade C) are phylogenetically distinct from
contemporary viruses from the Arabian Peninsula (clades A and B) but
remain antigenically similar in microneutralization tests. Viruses from
West (Nigeria, Burkina Faso) and North (Morocco) Africa form a
subclade, C1, that shares clade-defining genetic signatures including
deletions in the accessory gene ORF4b. Compared with human and
camel MERS-CoV from Saudi Arabia, virus isolates from Burkina Faso
(BF785) and Nigeria (Nig1657) had lower virus replication compe-
tence in Calu-3 cells and in ex vivo cultures of human bronchus
and lung. BF785 replicated to lower titer in lungs of human DPP4-
transduced mice. A reverse genetics-derived recombinant MERS-CoV
(EMC) lacking ORF4b elicited higher type I and III IFN responses than
the isogenic EMC virus in Calu-3 cells. However,ORF4b deletions may
not be the major determinant of the reduced replication competence
of BF785 and Nig1657. Genetic and phenotypic differences in West
African viruses may be relevant to zoonotic potential. There is an
urgent need for studies of MERS-CoV at the animal–human interface.
MERS | coronavirus | evolution | Africa | zoonosis
Middle East respiratory syndrome (MERS) remains a dis-ease of global public health concern (1). Many human
infections are zoonotic in origin, but some result from clusters of
human-to-human transmission, especially within hospitals and
health care facilities (2). Zoonotic disease has been reported
from the Arabian Peninsula, and dromedary camels are the only
confirmed source of zoonotic infection (3). Although MERS-
coronavirus (MERS-CoV) is also endemic in dromedaries in
Africa, where the majority of dromedary camels are found (4–7),
zoonotic infections have not been reported from Africa. Hypotheses
for this pattern of zoonotic disease include genetic differences in the
viruses; cultural, behavioral, or dietary differences in interactions
between humans and camels and camel products; or unnoticed
human cases through lack of awareness and surveillance in African
countries. Data on phylogenetic and phenotypic characterization of
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MERS-CoV from Africa are limited. We previously reported
that MERS-CoV from Egypt and Nigeria appear to be phyloge-
netically distinct from those currently circulating in the Arabian
Peninsula (5, 6). We now report a comprehensive genetic and
phenotypic analysis of MERS-CoV from North (Morocco), West
(Nigeria, Burkina Faso), and East (Ethiopia) Africa compared
with viruses from the Arabian Peninsula.
Results
Genetic Characterization.The epidemiological aspects of field studies of
dromedary camels in Morocco, Burkina Faso, Ethiopia, and Nigeria,
including seroprevalence and RT-PCR detection of virus from nasal
swabs, have been reported previously (6, 7). An additional 102 nasal
swabs were collected in the Afar region of Ethiopia in 2017. Of 173
RT-PCR–positive specimens detected in these studies, those with
high viral load were selected, attempting to maximize diversity in
geography and sampling dates, for full viral genome sequencing
directly from the clinical specimen and for virus isolation (Dataset
S1). Three viruses from Burkina Faso, one from Morocco, nine
from Nigeria, and three from Ethiopia were fully sequenced, and
an additional virus from Ethiopia was sequenced from the S2 gene
region to the 3′ end of the genome (5,126 nt). Genetic nucleotide
identity was 99.17% within African camel virus genomes, >99.26%
within human and camel MERS-CoV from the Middle East, and
99.18–99.58% between viruses from the Middle East and Africa
(GenBank accession nos: MG923465–MG923481).
Phylogenetic analysis of these and other relevant viruses is
shown in Fig. 1. The tree was rooted against a MERS-CoV–
related bat coronavirus Neoromicia/PML-PHE/RSA/2011 (8).
Viruses from Nigeria, Burkina Faso, Morocco, and Ethiopia
formed a monophyletic clade together with previously sequenced
viruses from Egypt, which we now provisionally designate as virus
“clade C.” A time-resolved phylogeny of currently available
MERS-CoV sequences, including those generated in this study
from diverse parts of Africa, is shown in Fig. S1. An analysis of
synapomorphies (mutations inferred to have occurred once in
the tree), homoplasies (repeat mutations), and reversions within
available MERS-CoV full-genome sequences is shown in Fig. S2.
Viruses from Burkina Faso (n = 3), Morocco (n = 1), and Nigeria
(n = 9) had signature deletions in the ORF4b and/or ORF3 gene re-
gions (Fig. S3) and are designated “clade C1” (Fig. 1). Clade C viruses
from Ethiopia (n = 4) and Egypt (n = 3) did not have such gene
deletions, nor do the majority of viruses from the Arabian Peninsula.
However, sequences of two clade B human viruses detected in 2012
(Riyadh_1_2012 and Bisha_1_2012) available in public databases also
have short (17-nt) deletions in theORF4b region in a similar, although
not identical, region as the African isolates (Fig. S3). Targeted se-
quencing of the ORF3/4b gene region was done on additional African
camel viruses from which full genomes could not be obtained because
viral load was too low. Overall, all 10 additional viruses from Burkina
Faso carried these same signature deletions, frame shift mutations, or
premature stop-codons that markedly reduced the size of the ORF4b,
but none of the 10 additional viruses from Ethiopia did so (Fig. S3).
Clade C1 viruses withORF4b deletions appear to share a common
ancestor, with a 6-nt and a 360-nt deletion in ORF4b denoted as
the “ancestral type i ORF4b deletion” in the phylogenetic tree
(Fig. 1) and in the schematic of the deletion (Fig. S3). This de-
letion has been added to progressively, and these deletions are
denoted as “ii,” “iii,” “iv,” and “v” along the branches of the phy-
logenetic tree (Fig. 1) and the schematic (Fig. S3). Some of these
viruses (Nigeria/HKU NV1657-like and Burkina Faso/CIRAD-
HKU697-like) have also acquired deletions in ORF3. Notably, the
Ethiopian and Egyptian viruses encoded a full-length ORF3.
The impact of the different ORF4b deletion events on the
functional domains of the putative protein are shown in Fig. S4.
The type i/v deletion found in BF785 and BF434 viruses truncated
the ORF4b protein from 246 aa found in the EMC prototype
MERS-CoV EMC to 14 aa, deleting the whole of the nuclear
localization signal as well as the enzymatic domain that cleaves
2′,5′-oligoadenylate (9). Nig1657 retains the nuclear localization
signal and part of the phosphodiesterase (PDE) domain and
is truncated to 71 aa. All these deletions disrupt the PDE
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Fig. 1. Phylogenetic analysis of MERS-CoV full and partial genomes using the maximum-likelihood method (PhyML). Posterior probabilities of nodes with
values higher than 0.8 are shown. The tree is rooted against a MERS-CoV–related bat coronavirus Neoromicia/PML-PHE1/RSA/2011 (GenBank accession no.
KC869678). The long branch leading to Neoromicia/PML-PHE1/RSA/2011 has been removed to allow greater resolution of the viruses of interest. Fourteen
virus genomes from African camels from this study are highlighted in red, and abbreviations for the viruses are given in square brackets. Clade C and subclade
C1 MERS-CoV from African camels are denoted. Five deletion events (i–v) for viruses in clade C1 deduced from the deletion patterns affecting ORF3 and
ORF4b (Fig. S3) are indicated at the respective branches.
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catalytic site. ORF4b encoded a polypeptide known to be an
IFN antagonist (10, 11). The N-terminal region of ORF4b en-
codes the nuclear localization signal. Deletion of this region ab-
rogated nuclear localization and led to a loss of suppression of
IFN-β induction via the IRF3- and IRF7-signaling pathways.
However, it did not affect suppression of IFN-β via Tank-binding
kinase 1 and IκB kinase, which was demonstrated in transient
transfection experiments and appears to be mediated by the
C-terminal domain of ORF4b (10). These data come fromORF4b
protein overexpression and may or may not be physiologically
relevant. The two Saudi Arabian clade B viruses Riyadh_1 and
Bisha_1 had less extensive deletions of the PDE domain, although
they also disrupt the PDE catalytic site.
Deletions and insertions at the 3′ end of ORF3 from viruses
from Nigeria (including Nig1657) and five viruses from Burkina
Faso (BF697, BF698, BF748, BF750, and BF764) resulted in the
truncation of the 103-aa ORF3 polypeptide to 98, 88, or 84 aa
(Fig. S3). The ORF3 deletions occurred only in those viruses
from Nigeria with type i/ii ORF4b deletions and in some viruses
from Burkina Faso with type i/iii ORF4b deletions. These dele-
tions occurred near the 3′ end of ORF4b and ORF3 and did not
affect the integrity of transcription regulator sequences (12) of
downstream genes. They are therefore unlikely to affect the
transcription of subgenomic RNAs.
The amino acid residues of AH13, Nig1657, and BF785 that
differ from the prototype clade A MERS-CoV strain EMC occur
throughout the virus genome (Dataset S2). The amino acid se-
quence of the Egyptian virus NRCE-HKU270, an East African
virus most closely related to the West African clade C1 viruses, is
also included for comparison. The amino acid residues in the
receptor-binding domain of the spike proteins of the BF785 had
amino acid substitution T424I, while Nig1657 had amino acid
substitutions L495F and L588F. None of these amino acid substi-
tutions was at the receptor-interacting interface of the spike protein
and thus likely did not affect the affinity of the protein for the host
receptor, although L495F is close to the interacting interface.
The antigenic similarity of BF785 and Nig1657 was compared
with prototype strain EMC, AH13, and Egypt NRCE-HKU270
by microneutralization tests using serum from a dromedary
camel immunized with a vaccinia-vectored MERS-CoV strain
EMC spike vaccine (provided by B. L. Haagmans, Erasmus
University Medical Center, Rotterdam) (13) and two field-
collected dromedary camel sera from Saudi Arabia (Table S1).
Each serum neutralized all MERS-CoV to titer dilutions twofold
or less than observed with prototype virus EMC.
Phenotypic Characterization. Three viruses from Burkina Faso
and one from Nigeria were successfully isolated in cell culture,
viz., dromedary/Burkina Faso/CIRAD-HKU434/2015 [BF434],
dromedary/Burkina Faso/CIRAD-HKU482/2015 [BF482], dromedary/
Burkina Faso/CIRAD-HKU785/2015 [BF785], and dromedary/
Nigeria/HKU NV1657 [Nig1657]. A representative dromedary virus,
BF785, with ORF4b deletion type i/v, the most extensive deletion of
ORF4b without any ORF3 indel, and Nig1657, with partial deletion
of ORF4b (type i/ii) together with an ORF3 deletion, were selected
for detailed phenotypic characterization. We confirmed that the
limited passage of virus isolates in cell culture had not extended
the ORF deletions observed in direct sequences from the specimen.
These viruses were compared with the prototype MERS-CoV EMC
strain (clade A) and a dromedary virus isolated in the Kingdom of
Saudi Arabia AH13 (clade B). Neither EMC nor AH13 has trun-
cations in ORF4b or ORF3.
Calu-3 cells, a human adenocarcinoma cell line of bronchial
epithelial origin that retains innate immune function, were in-
fected at a multiplicity of infection (MOI) of 0.01. EMC and
AH13 strains replicated comparably with each other, while
BF785 and Nig1657 replicated to significantly lower titer at
24 and 48 h postinfection (Fig. 2A) and area-under-curve (AUC)
analysis (Fig. S5A). Similar observations were made in Calu-
3 cells infected at an MOI of 0.1 with EMC, AH13, and
BF785 viruses (Fig. S5 B and C). In experimentally infected
C57BL/6 mice made susceptible to infection with MERS-CoV by
transducing the human dipeptidyl peptidase receptor (hDPP4)
using an adenovirus type 5 vector expressing hDPP4 (14),
BF785 viral titers in the lung were significantly lower than EMC
or AH13 virus titers at both day 3 and day 5 post infection, the
difference in viral titers being >2log10 at 3 d post infection (Fig.
2B), although histology did not reveal obvious differences in
pathology (Fig. S6). MERS-CoV BF785 and Nig1657 replicated
less efficiently than EMC in ex vivo cultures (15) of human
bronchus and lung (Fig. 2C; Fig. S5D shows the AUC). The
immunohistochemistry of infected human bronchus and lung did
not reveal any obvious difference in tropism (Fig. S5E).
A genetic feature observed in BF785 and Nig1657 was the
deletion in ORF4b. ORF4b gives rise to a gene product that is
reportedly associated with evasion of host cell IFN defense mech-
anisms (10, 11), and these deletions would be expected to impact
ORF4b function. We therefore compared innate immune responses
elicited in Calu-3 cells by infection with EMC, AH13, BF785 (which
has most of its ORF4b gene deleted), and Nig1657 (which has
ORF4b partially deleted as well as an ORF3 deletion) viruses after
infection at an MOI of 2 (Fig. 3). A highly pathogenic avian in-
fluenza virus, A/HK/483/1995(H5N1), was used as a positive control
of cytokine and IFN-stimulated gene (ISG) expression. UpE gene
expression in MERS-CoV–infected cells confirmed that BF785 and
Nig1657 had lower replication than EMC and AH13 (Fig. 3A).
IFN-β, IFN-λ1/IL-29, IP-10 (CXCL10), ISG15, and Mx1 mRNA
expression was strongly up-regulated as early as 24 h post infection
in H5N1-infected cells, at which time there was minimal induction
of these genes in MERS-CoV–infected cells (Fig. 3 B–G). By 48 h
after infection IFN-β, IFN-λ1/IL-29, IP10 (CXCL-10), ISG15,
MX1, and TNF-α mRNA was detectable in cells infected with all
Fig. 2. Comparison of virus replication kinetics in Calu-3 cells, human DPP4-
transduced mice, and ex vivo cultures of the human bronchus and lung.
(A) Calu-3 cells were infected at an MOI of 0.01, and virus titers in culture
supernatants were determined by the 50% tissue culture infective dose per
milliliter (TCID50) assay. The horizontal dotted line denotes the limit of de-
tection in the TCID50 assay. Statistical significance was determined by two-way
ANOVA with Bonferroni’s correction: *P < 0.05; **P < 0.01; ***P <
0.001 compared with EMC; ###, P < 0.001 compared with AH13; +, P < 0.05; +++,
P < 0.001 compared with BF785. Each experiment was repeated once, and
one representative experiment is shown. (B) Ad5-hDPP4–transduced C57BL/
6 mice (7 wk old, female) were infected intranasally with 1 × 104 pfu of
MERS-CoV strains EMC, AH13, or BF785. Virus titers in the lungs were
measured. The horizontal dotted line denotes the limit of detection. Titers are
expressed as pfu per gram of tissue. n = 3 mice per group at each time point.
Statistical significance was determined by two-way ANOVA with Bonferroni’s
comparisons: ***P < 0.001 compared with EMC; ###, P < 0.001 compared with
AH13. (C and D) Comparison of virus replication and tropism of MERS-CoV EMC,
BF785, and Nig1657 in ex vivo cultures of human bronchus (C) and lung (D). Virus
titers in culture supernatants were determined by TCID50 assay. Data are the
means and SEM of three individual tissue donors. The horizontal dotted line
denotes the limit of detection in the TCID50 assay. Statistical significance was
determined by two-way ANOVAwith Bonferroni’s comparisons: *P < 0.05; **P <
0.01 compared with EMC.
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four MERS-CoV isolates, but levels remained markedly lower than
in H5N1-infected cells. IFN-β, IFN-λ1/IL-29, and IP-10 (CXCL-10)
mRNA in BF785-infected cells was significantly higher than that
seen in EMC but was not higher than in AH13-infected cells.
Nig1657-infected cells had significantly lower levels of IFN-β, IFN-
λ1/IL-29, IP10 (CXCL-10), ISG15, andMX1mRNA compared with
AH13- or BF785-infected cells (Fig. 3 B–F). IP-10 (CXCL10) pro-
tein levels in the supernatants of the four MERS-CoV–infected cells
were below the limits of detection or were very low compared with
H5N1-infected cells (Fig. 3H). We also investigated the sensitivity of
the four MERS-CoV to increasing concentrations of IFN-β in Vero
cells and found no biologically relevant difference between the
Saudi Arabian and African viruses (Fig. S7). All four MERS-CoV
were markedly more sensitive to IFN-β than has been reported for
Severe acute respiratory syndrome coronavirus (SARS-CoV) (16).
Phenotype of ΔORF4b EMC Virus. To directly address whether the
ORF4b deletion affects viral replication competence, we used
reverse genetics to derive a recombinant EMC virus carrying the
ORF4b deletion (rgEMCΔ4b) and compared this with an isogenic
recombinant wild-type virus (rgEMC-WT). Replication compe-
tence of rgEMCΔ4b virus in Calu-3 cells infected at an MOI of
0.01 was not significantly different from rgEMC-WT virus as
assessed by infectious virus titers at 24 h post infection, although it
was reduced at 48 and 72 h post infection (Fig. 4A). In Calu-3 cells
infected at an MOI of 2.0, viral UpE gene expression was compa-
rable or lower in rgEMCΔ4b-infected cells (Fig. 4B), but the ex-
pression of IFN-β, IFN-λ1/IL-29, CXCL10 (IP-10), ISG15, Mx1,
and TNF-α was significantly higher (Fig. 4C and Fig. S8).
Discussion
Studies of MERS-CoV in dromedaries in Burkina Faso (West
Africa), Nigeria (West Africa), Morocco (North Africa), and
Ethiopia (East Africa) showed that virus circulation was as extensive
and viral shedding as common as previously reported in the Arabian
Peninsula (7). However, while zoonotic MERS has been repeatedly
reported from the Arabian Peninsula, zoonotic human disease has
not so far been reported in Africa. There are, however, little viral
genetic data from MERS-CoV in Africa. To begin to address
this knowledge gap, we genetically characterized MERS-
CoV from Burkina Faso, Nigeria, Morocco, and Ethiopia. We
found that MERS-CoV circulating in dromedaries in Africa
are phylogenetically distinct from viruses in the Arabian Peninsula.
There are no homoplasies (convergent mutations) shared between
the African and Saudi clades, suggesting no recombination between
these lineages (consistent with a single or just a few introductions
into the Kingdom of Saudi Arabia and limited further contact be-
tween the lineages). MERS-CoV from North and West Africa form
a distinct subclade (clade C1) within those from Africa, and they
have characteristic deletions in ORF4b, an accessory gene that has
been previously reported to be an IFN antagonist (10, 11). Some of
these viruses also have partial deletions of ORF3. The biological
function of ORF3 still remains unclear. Dromedary camel move-
ments in Africa occur more in the north–south direction with
movements between countries such as Morocco, Burkina Faso, and
Nigeria being more much likely than east–west movements, i.e.,
between West Africa and Ethiopia or Egypt (17). This may explain
the observed separate phylogenetic clustering of viruses from West
and North Africa as clade C1, which were also the viruses that have
the ORF4b gene deletions. Although genetically distinct, MERS-
CoV from West Africa were antigenically similar to the prototype
EMC virus (clade A), AH13 (clade B), and Egypt NRCE-HKU270
(clade C, nonclade C1) viruses in microneutralization tests. Thus, it
is likely that neutralizing antibodies elicited by the prototype strain
EMC in putative vaccines are likely to be cross-protective against
these genetically diverse African strains.
We successfully isolated representative clade C1 viruses from
West Africa (BF785 from Burkina Faso and Nig1657 from
Nigeria) for phenotypic characterization in comparison with
human clade A (strain EMC) virus and a camel clade B (AH13)
virus from Saudi Arabia. BF785 has the most extensive deletion of
the ORF4b gene product, with loss of the whole PDE domain
as well as the nuclear-localizing signal, while Nig1657 retains the
nuclear-localizing domain and part of its PDE domain, although the
PDE catalytic site is lost. Compared with EMC and AH13, both
BF785 and Nig1657 viruses had significantly reduced replication
competence in Calu-3 cells as assessed by titration of infectious
virus at 24 and 48 h post infection at MOIs of 0.01 and 0.1, re-
spectively. In contrast, we had previously demonstrated that the
East African dromedary/Egypt-NRCE-HKU-270/2013 had com-
parable or better replication competence than EMC and AH13
viruses in Calu-3 cells (15). Compared with EMC and AH13, the
BF785 virus also had reduced replication competence in vivo in the
Fig. 3. Comparison of innate immune responses in Calu-3 cells infected with different MERS-CoVs: EMC, AH13, BF785, or Nig1657. Calu-3 cells were infected
with MERS-CoV at an MOI of 2. Influenza A/HK/483/1997 (H5N1) was used as a positive control for cytokine induction, and mock-infected cells served as
negative controls. Cell lysates were collected at 6, 24, and 48 h postinfection, and mRNA was extracted. The RNA expression of viral gene (UpE) (A), mRNA
expression of IFNs (IFN-β, and IFN-λ1) (B and C), IFN-inducible genes IP-10 (D), ISG15 (E), and MX1 (F), and a proinflammatory cytokine TNF-α (G) is shown
as the mean and SEM of three biological replicates. The detection limit of each gene was 20 copies. (H) The cell-culture supernatants were tested for
IP-10 protein using the BD Cytometric bead-assay (detection limit 7.54 pg/mL). The experiment was carried out with three biological replicates. Statistical
significance was determined by two-way ANOVA with Bonferroni’s correction and is indicated as *P < 0.05; **P < 0.01; ***P < 0.001.
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lungs of Ad5-hDPP4–transduced mice and in ex vivo cultures of
human bronchus and lung. The mouse model used does not man-
ifest overt clinical disease, and thus a comparison of disease severity
was not possible (14). It is notable that the impaired virus replica-
tion competence of the West African viruses in human respiratory
epithelial cells does not appear to impair the fitness of these viruses
in transmitting between dromedaries because these viruses are
widespread in camels in West Africa (4, 5, 7).
Because BF785 and Nig1657 differ from EMC and AH13 in
having deletions in the ORF4b gene, and because the ORF4b gene
product is reportedly associated with evasion of host cell IFN de-
fense mechanisms (10, 11), we further investigated whether the
impaired replication competence correlated with a loss of such
immune evasion in Calu-3 cells. In contrast to influenza H5N1,
which was a potent inducer of IFN-β, IFN-λ1, IP10, ISG15, and
Mx1 by 24 h post infection, the four MERS-CoV had little effect
in up-regulating these innate immune responses at 24 h post in-
fection, suggesting that potent innate immune-evasion mecha-
nisms remained active in all four coronaviruses despite the ORF4b
deletion in BF785 and Nig1657 viruses (Fig. 3). Coronaviruses
have multiple antagonists of IFN induction and signaling, and thus
deletion of ORF4b by itself may not be decisive in this regard. By
48 h post infection, there was detectable induction of innate im-
mune responses by someMERS-CoV, although this was still much
lower than those elicited by H5N1 virus. Nig1657 also has dele-
tions in ORF3. No consistent pattern was discerned between in-
nate immune responses (or evasion of such responses) and the
impaired virus replication competence of BF785 and Nig1657.
Taking these findings together, we conclude that the impaired repli-
cation phenotype was not associated with the lack of innate immune
evasion. In contrast, it was recently reported that a recombinant
MERS-CoV clone with ORF3/4/5 deletions had reduced virus
replication competence in Calu-3 (but not Vero) cells and in the
lungs of human DPP4-transgenic mice, suggesting that the com-
bined loss of these ORFs does lead to attenuation of the virus (18).
To specifically investigate whether the ORF4b deletion con-
tributed to reduced replication competence, we compared
recombinant EMC (rgEMC-WT) with an isogenic virus that was
deleted in ORF4b (rgEMCΔ4b). We found rgEMCΔ4b viral ti-
ters did not significantly differ from rgEMC-WT at 24 h repli-
cation, in contrast with BF785 and Nig1657 viruses where
replication was significantly reduced at this time. Thus, the
ORF4b deletions in BF785 and Nig1657 were likely not major
contributors to the reduced virus replication observed in clade
C1 virus-infected cells. At 48 h post infection rgEMC-WT rep-
licated to modestly lower titers compared with rgEMCΔ4b.
The rgEMCΔ4b virus elicited significantly higher mRNA ex-
pression of IFN-β, IFN-λ1, CXCL10 (IP-10), ISG15, and MX1 in
rgEMCΔ4b-infected cells. Previous evidence for an IFN antag-
onist role for ORF4b protein (10, 11) was based solely on the
overexpression of ORF4b, while our data were generated from
an isogenic deletion mutant virus. Increased mRNA of type I
IFN and type III IFN as well as TNF-α suggests that ORF4b has
effects on IRF-3 as well as NFκB pathways.
Taken together, our data suggest that BF785 and Nig1657
have reduced replication competence in Calu-3 cells and in ex
vivo cultures of human bronchus and lung and, in the case of
BF785, also have reduced replication competence in Ad5-
hDPP4–transduced mice (comparable experiments were not
carried out with Nig1657). Although these viruses have dele-
tions in ORF4b, this does not appear to be the major explanation
for the reduced viral replication competence of clade C1 viruses.
It is relevant that two clade B viruses, Riyadh_1_2012 and
Bisha_1_2012, which also have ORF4b deletions, have previously
been isolated from patients with severe human disease. Thus,
ORF4b deletions by themselves are unlikely to contribute to al-
tered zoonotic transmission of West African viruses. Further-
more, in previous experiments where EMC virus has been
serially passaged in mice to derive mouse-adapted MERS-CoV,
such mouse adaptation and increase in virulence for mice have
often been associated with deletions or frameshift mutations in
all the accessory proteins, including ORF5 (19, 20). Recently, a
clade B MERS-CoV with a deletion in ORF4a (a different ac-
cessory gene) and a minor deletion in ORF3 has been isolated
from humans diagnosed as part of a hospital outbreak in Jordan
(21). All 13 viruses from patients sampled during this outbreak
had this ORF4a deletion, indicating that these viruses were
transmissible in humans. ORF4a is also known to be an IFN an-
tagonist acting by binding and antagonizing the dsRNA-binding
protein PACT (22). It is not yet reported whether ORF4a dele-
tions in these human MERS-CoV affect IFN responses or virus
replication competence.
Differences in viral genes other than ORF4b or ORF3 genes likely
contribute to the impaired viral replication of BF785 and Nig1657.
MERS-CoV BF785 and Nig1657 differ from EMC in several pro-
teins, including nsp1, nsp2, nsp3, nsp4, nsp5, nsp6, nsp7, nsp8, nsp12,
nsp13, nsl14, nsp15, and nsp16, the spike protein, ORF3/4/5 gene
regions, and N protein (Dataset S2). The spike protein is a crucial
determinant of virus tropism and interspecies transmission. However,
none of the amino acid differences between Arabian and West Af-
rican viruses is in the receptor-binding interface.
The observation that ORF4b, ORF4a, and ORF3 deletions
appear to arise independently in clade B and C viruses and that
ORF4b deletions are fixed in MERS-CoV from dromedaries
West Africa may suggest that the virus is not yet fully adapted to
camels and the presence of these genes is either neutral or
slightly deleterious to virus growth in these settings. Given the
propensity of viruses to discard unnecessary genetic information,
these results suggest that these accessory proteins are advanta-
geous in some other reservoir host species, perhaps bats. The
time to most recent common ancestor (TMRCA) for MERS-CoV,
the >99% nucleotide homology of viruses across a wide geo-
graphic area, the genetic instability of the virus in dromedaries,
and the lack of endemic infection in dromedaries in parts of the
Fig. 4. Comparison of virus replication kinetics and innate immune responses in Calu-3 cells infected with reverse-genetically engineered MERS-CoV, rgEMC-
WT, and MERS-CoV with ORF4b deletion, rgEMCΔ4b. (A) Calu-3 cells were infected at an MOI of 0.01. Virus titers in culture supernatants were determined by
the TCID50 assay. Means and SEM of three biological replicates are shown. The horizontal dotted line denotes the limit of detection in the TCID50 assay. (B and
C) Calu-3 cells were infected at an MOI of 2 with MERS-CoVs rgEMC-WT and rgEMCΔ4b; mock-infected cells served as negative controls. RNA expression of
viral gene UpE (B) and mRNA expression of IFN-β and IFN-λ1 (C) is shown as the mean and the SEM of three biological replicates. The detection limit of each
gene was 20 copies. Each experiment was repeated once, and a representative experiment is shown. Statistical significance was determined by two-way
ANOVA with Bonferroni’s comparisons: *P < 0.05; **P < 0.01; ***P < 0.001.
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world (e.g., Kazakhstan) (23) suggest that MERS-CoV has not
been endemic in dromedary camels for very long. However, the
presence of antibodies to a MERS-CoV–like coronavirus in
dromedary sera from Africa and the Middle East collected 30 y
ago indicates that the virus has been transmitting in camels for at
least this period of time (4). Taken together, these data may
suggest that dromedaries, although currently the source of zoo-
notic infection, are themselves a relatively recent host of MERS-
CoV and that the virus is still adapting to this species.
In conclusion, MERS-CoV in Africa are phylogenetically
distinct but antigenically similar to those currently circulating in
the Arabian Peninsula. Clade C1 MERS-CoV that are enzootic in
dromedaries in West Africa had lower replication competence
in human respiratory epithelium in vitro, in cultures of human
bronchus and lung ex vivo, and in the lungs of experimentally
infected mice. The genetic determinants of this reduced virus
replication competence of clade C1 viruses remains to be estab-
lished. It is possible that these observations may be relevant to
explain the apparent lack of zoonotic disease in West Africa. It is
important to note that viruses from Egypt were not phenotypically
different to those from the Arabian Peninsula, and thus there is no
indication that MERS-CoV from East Africa have reduced zoo-
notic potential. These findings highlight the need for more ex-
tensive and sustainable surveillance and monitoring systems,
especially in East Africa, including seroepidemiologic studies in
humans regularly exposed to dromedaries, to ascertain whether
unrecognized zoonotic MERS infections are taking place.
Materials and Methods
Details of the study sites (6, 7), specimen collection, and RT-PCR detection of
MERS RNA are detailed in Supporting Information. Representative swab
specimens with high MERS-CoV viral load [low threshold cycle (CT) values]
were selected for full-length virus genome sequencing, and additional
specimens were selected for targeted sequencing of the ORF3 and ORF4b
regions (Supporting Information). Methods used for virus isolation and for
the assembly and modification of a full-length BAC cDNA clone to rescue
wild-type and mutant recombinant MERS-CoV lacking ORF4b are described
in Supporting Information.
Phylogenetic Analysis and Phenotypic Comparison of MERS-CoV Isolates. The
phylogenetic analysis shown in Fig. 1 was done using the maximum-likelihood
method (PhyML) (24). Other phylogenetic methods are detailed in Supporting
Information. Dromedary virus BF785 and Nig1657 viruses isolated as part of
this study were chosen for comparison with the prototype human MERS-CoV
strain EMC (clade A) provided by R. A. M. Fouchier (Erasmus University
Medical Center, Rotterdam, The Netherlands) and a dromedary camel virus,
dromedary/Al-Hasa-KFU-HKU13/2013 (AH13) (clade B), isolated in the King-
dom of Saudi Arabia (25). Viruses were isolated and grown in Vero cells, ali-
quoted, and stored at −80 °C until used. The passage history of these viruses is
shown in Dataset S1. Antigenic comparison also included dromedary/Egypt
NRCE-HKU-270 (15).
Phenotypic comparison of viruses in Calu-3 cells and ex vivo cultures of
human lung and bronchus were carried out as described in Supporting In-
formation. The procedure for transducing mice with an adenovirus vector
expressing human DPP4 has been previously described (14) and is detailed in
Supporting Information.
Biosafety and Ethics. Experiments with live MERS-CoV were carried out in
biosafety level 3 biocontainment facilities at the University of Hong Kong and
the University of Iowa. Studies on the ex vivo cultures of human bronchus and
lung were approved by the Institutional Review Board of The University of
Hong Kong/Hospital Authority Hong Kong West Cluster (UW-13-104). All
animal studies were approved by the Institutional Animal Care and Utiliza-
tion Committee at the University of Iowa.
Statistical Analysis. The statistical analyses are indicated in figure legends and
are detailed in Supporting Information. Statistical significance was defined
as P < 0.05.
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